FDA Inspection 1106964 — Essential Pharmaceutical Corp

Essential Pharmaceutical Corp — FEI 3004843655

The FDA completed an inspection of Essential Pharmaceutical Corp on October 17, 2019 in Pomona, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 12 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 17, 2019
Fiscal Year
2020
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Pomona, CA (United States)

Citations

IDCFRDescription
1551121 CFR 111.27(d)Equipment - maintain - general
1553221 CFR 111.255(b)Batch record - complete
1576121 CFR 111.205(b)(1)Master manufacturing record - specifications; quality
1582921 CFR 111.70(b)(1)Specifications - component identity
1583021 CFR 111.70(b)(2)Specifications-component purity, strength, composition
1583821 CFR 111.70(d)Specifications - labels, packaging
1583921 CFR 111.70(e)Specifications - identity, purity, strength, composition
1593121 CFR 111.105Quality control - packaged, labeled
1593221 CFR 111.105(a)Quality control - processes, specifications, written procedures
1596321 CFR 111.113(b)(2)Quality control - reject; specification not met
1598121 CFR 111.123(a)(5)Quality control operations - reprocessing
1607021 CFR 111.35(b)(2)Document-equipment date of use, maintain, clean, sanitize